Abstract
ObjectiveIn the light of increased adverse outcomes for people with diabetes affected by COVID‐19, we have described the clinical course of a cohort of critically ill patients with COVID‐19 and diabetes.MethodsWe retrospectively analysed characteristics, glucometrics and inflammatory markers of patients with diabetes mellitus admitted to intensive care unit (ICU) with COVID‐19.ResultsEight patients with diabetes were admitted to ICU with COVID‐19. All had type 2 diabetes, with three being newly diagnosed that admission. Mean HbA1c was 9.2%. Glucometric analysis indicated that extremely high insulin doses were required during peak inflammatory response to maintain glycaemic control with a mean peak insulin requirement of 201 units per day (2.2 units/kg/day).ConclusionsCritically unwell patients with diabetes mellitus and COVID‐19 had high insulin requirements and poorer time in target range at the time of peak inflammatory response, and this improved as their illness resolved.
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
